US EditionPublished • loading... • Updated
EspeRare receives a grant from the Gates Foundation to advance a novel therapy for preeclampsia
Summary by PR Newswire
10 Articles
10 Articles
PR Newswire+9 Reposted by 9 other sources
EspeRare receives a grant from the Gates Foundation to advance a novel therapy for preeclampsia
/PRNewswire/ -- EspeRare, a pioneering Geneva-based nonprofit biotech, announced today that it has been awarded a Grand Challenges grant from the Gates...
·United States
Read Full ArticleCoverage Details
Total News Sources10
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
